IFNA1 and neoplasm: Overall, our scRNA-seq analysis of XX and XY GBM tumors provides validation and a more comprehensive understanding of XX-biased IFN responses in TAM-MGs and their anti-tumor effects through T-cell and other GBM immune cell interactions.